|
MLST
|
n
|
Non-susceptibility (%) to Antimicrobials
|
|---|
|
PCN
|
CTX
|
CLP
|
TCL
|
CLM
|
ETM
|
LFC
|
TSZ
|
|---|
|
CC81
|
37
|
10.8
|
0
|
94.4
|
97.2
|
63.9
|
97.3
|
0
|
80.6
|
|
CC90
|
12
|
0
|
0
|
75.0
|
91.7
|
100
|
100
|
0
|
100
|
|
CC166
|
17
|
11.8
|
17.6
|
35.3
|
100
|
100
|
100
|
0
|
100
|
|
CC320
|
71
|
42.3
|
62.0
|
12.7
|
100
|
97.2
|
100
|
1.4
|
87.1
|
|
CC554
|
13
|
0
|
0
|
76.9
|
84.6
|
92.3
|
92.3
|
0
|
23.1
|
|
CC880
|
10
|
0
|
10
|
10.0
|
100
|
100
|
100
|
0
|
70.0
|
|
ST338
|
6
|
0
|
0
|
0
|
100
|
100
|
100
|
0
|
0
|
|
ST3280
|
9
|
0
|
0
|
0
|
100
|
0
|
100
|
0
|
100
|
|
ST3385
|
8
|
0
|
12.5
|
12.5
|
12.5
|
0
|
12.5
|
0
|
0
|
- MLST multilocus sequence typing, CC clonal complex, ST sequence type, n number, PCN penicillin, CTX cefotaxime, CLP chloramphenicol, TCL tetracycline, CLM clindamycin, ETM erythromycin, LFC levofloxacin, TSZ trimethoprim-sulfamethoxazole
